The first quarter of 2021 was challenging for the biotechnology industry, as the selloff in March represented a sharp reversal from record highs in February. While the sector has remained relatively r

Moving Beyond COVID In Biopharma

09:31am, Thursday, 15'th Apr 2021

Just over one year after COVID-19 disrupted our lives, we are now getting to the point where multiple vaccine options are nearly ubiquitous for those in the United States. Per the CDC, as of April 12,

Healthcare: A Wide Choice Of Large And Well-Established Companies

02:41am, Friday, 19'th Feb 2021

The advantage for dividend investors in this sector is the wide choice of large and well-established companies. AbbVie is a drug company with strong exposure to the immunology and the oncology markets

Pharma ETFs in Focus Post Q4 Earnings

01:38pm, Friday, 05'th Feb 2021

Healthcare Q4 results seem robust given that it is the fourth-best sector from a revenue growth look and the sixth-strongest in terms of earnings growth.

4 Pharmaceutical Stocks That Aren't Worth Their Outsized 2020 Gains

01:01pm, Tuesday, 01'st Dec 2020

Now that companies such as Pfizer, Moderna and AstraZeneca have emerged with viable vaccines against Covid-19, the hype around many pharmaceutical stocks is fading. Here are four stocks investors shou

7 Pharmaceutical Stocks to Buy for 2021 and Beyond

10:10am, Tuesday, 17'th Nov 2020

Pharmaceutical stocks help make the world go round. Without them, common ailments would plague our lives.

7 Healthcare Stocks That Can Survive Massive Reform

10:23am, Monday, 02'nd Nov 2020

These seven healthcare stocks may represent robust long-term investments no matter how reforms in the sector may develop post-election. The post 7 Healthcare Stocks That Can Survive Massive Reform app

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by